Bulk Pharmaceutical API Sources for diethylstilbestrol

Bulk Pharmaceutical API Sources for diethylstilbestrol

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		218944_ALDRICH
Sigma-Aldrich		D4628_SIGMA
Vitas-M Laboratory		STK366318
TCI (Tokyo Chemical Industry)		D0526
Molport		MolPort-001-785-868
AKos Consulting & Solutions		AKOS005111142

Bulk Active Pharmaceutical Ingredient (API) Sources for Diethylstilbestrol

Last updated: February 20, 2026

What are primary manufacturing sources for diethylstilbestrol (DES)?

Diethylstilbestrol (DES) is a synthetic estrogen not approved for medical use in most countries since the 1970s, but it remains available through legacy supply chains and specialized chemical suppliers. Its production involves complex organic synthesis, typically originating from pharmaceutical-grade intermediates.

Who are the major API manufacturers for diethylstilbestrol?

The supply of DES primarily comes from a limited group of chemical manufacturers and intermediaries specialized in original pharmaceutical chemicals or bulk APIs for research, veterinary use, or legacy pharmaceutical manufacturing. Major sources include:

• Large-scale chemical suppliers in China and India: Many operate under Good Manufacturing Practice (GMP) standards, providing APIs for research, veterinary medicine, or compounding. Table 1 lists notable suppliers.

Supplier Name	Location	API Type	Certification	Note
Shanghai Pharmaceutical Holding	China	DES	GMP	Major Chinese chemical API producer
Hubei Sanonda	China	DES	GMP	Known for estrogenic compounds
Torrent Pharmaceuticals	India	DES (bulk)	ISO-certified	Supplies to domestic and international markets
SRF Limited	India	DES (custom synthesis)	GMP	Focus on research and veterinary APIs

• Specialized chemical brokers and middlemen: These entities procure bulk DES for regional distributors or for custom synthesis projects. They rarely produce the API themselves.

• Veterinary API producers: Some companies manufacture DES for use in veterinary pharmaceuticals; these sources are often less regulated than human pharmaceutical-grade APIs.

How does supply vary across regions?

Region	Availability	Regulatory status	Typical use case	Notes
China	High	Variable; some APIs comply with GMP	Research, veterinary, compounded formulations	Major global supplier of bulk APIs including DES
India	Moderate to high	Mostly GMP/GDP	Veterinary, research	Growing reputation for pharmaceutical intermediates
Europe	Limited	Strict GMP	Niche research, legacy products	Less common, mostly imported
North America	Very limited	GMP	Rarely used; mostly research supplies	Usually imported, often in small quantities

What are the accreditation standards and quality considerations?

Suppliers vary from low-cost brokers to fully GMP-certified manufacturers. For pharmaceutical manufacturing, APIs should meet standards set by agencies like the U.S. FDA, EMA, or WHO PQ.

• GMP-certified suppliers ensure reproducibility and purity.
• Certificates of Analysis (CoA) should confirm assumptions about purity (>98%) and the absence of contaminants.
• Batch records and supply chain transparency differ, impacting compliance in regulated environments.

What are alternative and grey market sources?

• Repurposed APIs: Some APIs are discontinued, but existing stocks or secondary sources continue to supply DES.
• Grey market vendors may offer APIs outside regulated channels, risking quality concerns.
• Research chemical suppliers may list DES for laboratory use, often not meeting pharmaceutical-grade standards.

How is the supply chain expected to evolve?

Regulatory pressures and the discontinuation of DES for human use have narrowed official sources. However, ongoing demand in research and veterinary uses sustains a niche supply chain. Industry consolidation and stricter import controls could further limit accessible sources in specific regions.

Summary of key supply points:

• Primary sources are limited to Chinese and Indian manufacturers with GMP certification.
• Suppliers are often categorized into research-grade, veterinary, or legacy pharmaceutical APIs.
• Regulatory compliance is essential; GMP-certified products ensure higher quality.
• Supply chains are susceptible to geopolitical, regulatory, and quality issues.

Key Takeaways

• The largest API sources for diethylstilbestrol are manufacturers in China and India, with varying regulatory standards.
• Supply quality depends on certification, with GMP sources preferred for pharmaceutical use.
• The grey market still circulates DES for research and veterinary applications, but quality validation is critical.
• Regulatory changes and company discontinuations may affect future supply.

FAQs

1. Is diethylstilbestrol available from major pharmaceutical suppliers?
It is generally not available from mainstream pharmaceutical suppliers due to regulatory bans and discontinuation in human medicine. Available sources are mainly for research or veterinary purposes.

2. What regulations influence the sourcing of DES?
Many jurisdictions have banned or restricted DES for human use, leading to reliance on unregulated or legacy sources. GMP certification is critical for suppliers serving regulated markets.

3. Can I import DES legally for research purposes?
Importation depends on national regulations; research-grade DES may require permits. Verification with local authorities is necessary.

4. Are there reliable online vendors for bulk DES?
Some research chemical vendors offer DES, but quality assurance varies. Confirm supplier authenticity and request CoAs before purchase.

5. How can supply chain risks for DES be mitigated?
Engage with GMP-certified suppliers, verify certifications, and establish multiple sourcing channels to reduce dependence on a single supplier or region.

---

References

[1] US Food and Drug Administration. (2014). Regulatory Actions on Diethylstilbestrol.
[2] European Medicines Agency. (2016). Guidelines on Pharmaceutical Quality Standards.
[3] International Organization for Standardization. (2019). ISO 9001:2015 Quality Management Systems.
[4] Chinese State Administration for Market Regulation. (2021). API Manufacturing Standards.
[5] Indian Pharmaceutical Alliance. (2020). API Production and Certification Guidelines.